DiaMedica Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for DiaMedica Therapeutics Inc. (DMAC) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents3.0352.904.7345.117.417.9716.82
Short-Term Investments41.1248.3528.7740.4120.100.000.00
Cash & Short-Term Investments44.1552.9033.5045.1127.517.9716.82
Accounts Receivable0.240.370.000.130.340.820.78
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.230.410.250.200.060.000.00
Total Current Assets44.6153.6833.8445.4427.928.8417.97
Non-Current Assets
Property, Plant & Equipment (Net)0.430.490.560.110.170.150.10
Other Non-Current Assets1.310.000.000.000.000.000.00
Total Non-Current Assets1.740.490.560.110.170.220.37
Total Assets46.3554.1634.4045.5528.109.0518.34
Current Liabilities
Accounts Payable0.942.700.731.481.101.260.87
Short-Term Debt0.100.000.000.000.000.000.00
Accrued Liabilities4.351.780.700.480.860.000.00
Other Current Liabilities4.350.770.670.480.480.000.00
Total Current Liabilities5.392.792.171.522.031.321.30
Non-Current Liabilities
Long-Term Debt0.240.320.400.000.050.120.02
Other Non-Current Liabilities0.000.000.000.000.000.000.00
Total Non-Current Liabilities0.240.320.400.000.050.120.02
Total Liabilities5.633.102.571.532.081.441.31
Stockholders' Equity
Retained Earnings-140.00-115.55-96.18-82.55-68.91-56.62-45.97
Accumulated Other Comprehensive Income0.020.01-0.07-0.050.000.000.00
Additional Paid-in Capital180.70166.61128.08126.5894.9364.2362.99
Shares Outstanding42.8237.9626.4426.440.000.000.00
Total Stockholders' Equity40.7251.0631.8344.0226.017.6217.03
Total Liabilities & Equity46.3554.1634.4045.5528.109.0518.34